Acorda Therapeutics

ACOR

25.30

0.00

0.0%

After Hours:

25.30

0.00

0.0%

Stock Price
Open: 25.15
Prev. Close: 25.30
Low/Hi: 24.70 - 25.55
52-Week: 16.40 - 37.36
Volumes
Equity: 540,773
90-Day Avg: 687,371
Option: 1,164
90-Day Avg: 994
Volatility
Today: 39.6
20-Day: 53.9
52-Week: 49.7
30-Day IV: 157.0 +0.6
IV Rank: 1.00 (Elevated)
Fundamental
Div. Yield: 0.0%
Earnings: 28-Apr (Est.)
P/E Ratio:
Market Cap: 1.2 B
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ACOR Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Sep-2016 30-Jun-2016 31-Mar-2016 31-Dec-2015
Cash and Cash Equivalents 127,940 137,400 431,414 153,204
Short Term Investments 0 0 0 200,101
Investments - - - -
Accounts Receivable 48,575 45,886 41,623 31,466
Inventory 40,935 55,553 39,667 36,476
Loans - - - -
Prepaid Expenses 15,639 18,709 14,312 16,079
Net Property Plant and Equipment 35,777 36,754 38,027 40,204
Other Current Assets 4,863 5,616 17,265 13,991
Current Assets 237,952 263,164 544,281 451,317
Goodwill and Intangibles 1,033,444 1,036,028 614,127 614,492
Long Term Investments 0 0 0 0
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 1,318,368 1,346,539 1,211,694 1,116,343
Short Term Debt 0 0 0 0
Other Non-Current Assets 11,195 10,593 15,259 10,330
Accounts Payable 18,557 29,554 21,355 14,233
Accrued Liabilities and Other Payables 89,374 96,388 73,475 66,133
Long Term Debt 297,111 294,854 292,624 296,576
Other Liabilities - - - -
Current Portion of Long Term Debt 1,134 1,126 1,117 1,169
Total Liabilities 651,602 664,997 527,682 513,318
Other Current Liabilities 9,057 9,057 9,057 9,057
Accumulated Other Comprehensive Income -3,615 -4,711 0 -119
Preferred Stock 0 0 0 0
Current Liabilities 118,122 136,125 105,004 90,592
Common Stock 46 46 46 43
Other Non-Current Liabilities 236,369 234,018 130,054 126,150
Additional Paid-In Capital 911,540 904,784 894,167 812,782
Treasury Stock -329 -329 -329 -329
Other Equity 0 9,904 0 0
Retained Earnings -240,876 -228,152 -209,872 -209,352
Total Equity 666,766 681,542 684,012 603,025
Period Ending 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 153,204 182,170 48,037
Short Term Investments 200,101 125,448 225,891
Investments - - -
Accounts Receivable 31,466 32,211 30,784
Inventory 36,476 26,837 26,172
Loans - - -
Prepaid Expenses 16,079 15,523 8,398
Net Property Plant and Equipment 40,204 46,090 16,525
Other Current Assets 13,991 26,949 28,051
Current Assets 451,317 409,138 367,333
Goodwill and Intangibles 614,492 615,774 17,459
Long Term Investments 0 0 93,299
Other Assets - - -
Long Term Receivables 0 0 0
Total Assets 1,116,343 1,080,679 607,127
Short Term Debt 0 0 0
Other Non-Current Assets 10,330 9,677 112,511
Accounts Payable 14,233 17,751 15,922
Accrued Liabilities and Other Payables 66,133 56,118 37,569
Long Term Debt 296,576 289,883 3,721
Other Liabilities - - -
Current Portion of Long Term Debt 1,169 2,037 2,005
Total Liabilities 513,318 540,424 166,774
Other Current Liabilities 9,057 38,477 41,147
Accumulated Other Comprehensive Income -119 -74 37
Preferred Stock 0 0 0
Current Liabilities 90,592 114,383 96,643
Common Stock 43 42 41
Other Non-Current Liabilities 126,150 136,158 66,410
Additional Paid-In Capital 812,782 761,026 678,686
Treasury Stock -329 -329 -329
Other Equity 0 0 0
Retained Earnings -209,352 -220,410 -238,082
Total Equity 603,025 540,255 440,353